"10.1371_journal.pctr.0010029","plos clinical trials","2006-10-20T00:00:00Z","Philip Bejon; Jedidah Mwacharo; Oscar Kai; Tabitha Mwangi; Paul Milligan; Stephen Todryk; Sheila Keating; Trudie Lang; Brett Lowe; Caroline Gikonyo; Catherine Molyneux; Greg Fegan; Sarah C Gilbert; Norbert Peshu; Kevin Marsh; Adrian V S Hill","Kenya Medical Research Institute, Centre for Geographical Medicine Research (Coast), Kilifi, Kenya; Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford, United Kingdom; London School of Hygiene and Tropical Medicine, London, United Kingdom; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom; Nuffield Department of Clinical Medicine, Oxford University, John Radcliffe Hospital, Oxford, United Kingdom","PB, PM, TL, CM, GF, NP, KM, and AVSH designed the study. PB, GF, and NP analyzed the data. PB enrolled patients. PB, OK, TM, PM, ST, SK, TL, SCG, NP, KM, and AVSH wrote the paper. JM, OK, TM, ST, SK, BL, CM, and SCG collected data or did experiments. JM, OK, ST, and SK were involved with the immunological laboratory studies. TM helped with data collection and fieldwork. TL was the project manger for this trial, and contributed to the trial design and management of this study. BL assisted with the experimental design and ensured accuracy of all the laboratory assays. CG was responsible for fieldwork to ensure that standards of informed consent were met and were continuously monitored to maintain those standards. CM assisted in designing the community engagement elements of the trial, which included helping to write the consent forms, to assess community understanding of the information, and systems to respond to issues raised. SCG designed the vaccines used in the study, produced seed stocks, carried out quality control, and assisted with regulatory submissions for the vaccines. KM was Dr. Bejons on-site PhD supervisor and had overall responsibility for the conduct of the trial in Kenya.","AVSH is cofounder of and an equity holder in Oxxon Therapeutics, a company developing prime-boost therapeutic vaccines. No other authors have any conflicts of interest.","2006","10","Philip Bejon","PB",16,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
